Sandra Codony,Carla Calvó-Tusell,Elena Valverde,Sílvia Osuna,Christophe Morisseau,M. Isabel Loza,José Brea,Concepción Pérez,María Isabel Rodríguez-Franco,Javier Pizarro-Delgado,Rubén Corpas,Christian Griñán-Ferré,Mercè Pallàs,Coral Sanfeliu,Manuel Vázquez-Carrera,Bruce D. Hammock,Ferran Feixas,Santiago Vázquez,Carla Calvó-Tusell,Sílvia Osuna,José Brea,Concepción Pérez,María Isabel Rodríguez-Franco,Rubén Corpas,Christian Griñán-Ferré,Mercè Pallàs,Manuel Vázquez-Carrera,Santiago Vázquez

Abstract:The pharmacological inhibition of soluble epoxide hydrolase (sEH) is efficient for the treatment of inflammatory and pain-related diseases. Numerous potent sEH inhibitors (sEHIs) present adamantyl or phenyl moieties, such as the clinical candidates AR9281 or EC5026. Herein, in a new series of sEHIs, these hydrophobic moieties have been merged in a benzohomoadamantane scaffold. Most of the new sEHIs have excellent inhibitory activities against sEH. Molecular dynamics simulations suggested that the addition of an aromatic ring into the adamantane scaffold produced conformational rearrangements in the enzyme to stabilize the aromatic ring of the benzohomoadamantane core. A screening cascade permitted us to select a candidate for an in vivo efficacy study in a murine model of cerulein-induced acute pancreatitis. The administration of 22 improved the health status of the animals and reduced pancreatic damage, demonstrating that the benzohomoadamantane unit is a promising scaffold for the design of novel sEHIs.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01601?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01601</a>.1H and 13C NMR spectra and elemental analysis data of the new compounds, HPLC trace for compound 22, representation of the active site volume fluctuations, non-covalent interactions between the inhibitors and the active site residues of sEH, analysis of active site water molecules in MD simulations, plots of the dihedral angle that describes the rotation of the benzohomoadamantane and adamantane moieties in the left-hand-side pocket of the sEH active site along the MD simulations, overlay of the X-ray and representative snapshot from the apo state and inhibitor-bound aMD simulations, pharmacokinetic data of compounds 20 and 22, and histologic scoring of pancreatic tissues of mice treated with 22 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01601/suppl_file/jm0c01601_si_001.pdf">PDF</a>).Molecular formula strings and data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01601/suppl_file/jm0c01601_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors

Discovery and optimization of piperazine urea derivatives as soluble epoxide hydrolase (sEH) inhibitors

Design, Synthesis, and In‐Vitro Evaluation of Novel Butanoic Acid Derivatives as Potential Soluble Epoxide Hydrolase Inhibitors

Progress on the Treatment for Hypertension of Epoxide Hydrolase and Its Mechanisms

Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors

Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products

Discovery of glycosidated glycyrrhetinic acid derivatives: Natural product-based soluble epoxide hydrolase inhibitors

Natural soluble epoxide hydrolase inhibitors from Inula britanica and their potential interactions with soluble epoxide hydrolase: Insight from inhibition kinetics and molecular dynamics

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent Vasodilators

A Comprehensive Review of Soluble Epoxide Hyådrolase Inhibitors Evaluating their Structure-Activity Relationship

Probing Ligand-Binding Modes and Binding Mechanisms of Benzoxazole-Based Amide Inhibitors with Soluble Epoxide Hydrolase by Molecular Docking and Molecular Dynamics Simulation.

Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade

From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis

In vivo-Active Soluble Epoxide Hydrolase-targeting PROTACs with Improved Potency and Stability

Inhibition of Soluble Epoxide Hydrolase by Cembranoid Diterpenes from Soft Coral Sinularia maxima: Enzyme Kinetics, Molecular Docking, and Molecular Dynamics

Natural soluble epoxide hydrolase inhibitors from Inula helenium and their interactions with soluble epoxide hydrolase

Rational Design of Benzylidenehydrazinyl-Substituted Thiazole Derivatives As Potent Inhibitors of Human Dihydroorotate Dehydrogenase with in Vivo Anti-arthritic Activity.

Isoxazole analogues of dibenzazepine as possible leads against ulcers and skin disease: In vitro and in silico exploration

Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors

STRUCTURE-BASED DESIGN OF PROTACS FOR THE DEGRADATION OF SOLUBLE EPOXIDE HYDROLASE

Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase